Mutation in the adiponectin gene may result in a significant decrease in concentration of its target protein, which is associated with increased risk for coronary artery disease, insulin resistance, obesity, type 2 diabetes mellitus, and its complications [11,12,13]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.